首页> 外文期刊>Acta Radiologica >Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis
【24h】

Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis

机译:用于澄清乳房X XMPOCHIBIRS 3病变的乳房染色体合成可以降低随访检查并使癌症诊断立即实现

获取原文
获取原文并翻译 | 示例
           

摘要

Background The limited sensitivity of mammography in case of a high breast density often produces unclear or false-positive findings, so-called BI-RADS 3 lesions, which have to be followed up to prove benignity. Digital breast tomosynthesis (DBT) was developed to reduce such summation effects. Purpose To evaluate the influence of an additional DBT on the management of mammographic BI-RADS 3 findings and whether DBT can decrease the time to definitive diagnosis or not. Material and Methods We analyzed 87 patients with a mammographic non-calcified BI-RADS 3 lesion who underwent an additional DBT of the affected breast. A follow-up two-dimensional (2D) examination or a histological result of the lesion had to be available. The images were analyzed especially for the BI-RADS category and incremental diagnostic accuracy. Moreover, the inter-reader reliability and the radiation dose were evaluated. Results The BI-RADS category has been changed by the addition of DBT: 57.1% were assessed as BI-RADS 1 or 2, 4.6% as BI-RADS 4, and only 38.3% remained as BI-RADS 3. The intraclass correlation coefficient for the three readers showed a good agreement for inter-reader reliability. No false-negative examination was found in the follow-ups. Nine lesions were biopsied (seven benign, two malignant). Both malignant lesions were suspicious in the DBT (BI-RADS 4). A significant higher glandular dose was necessary for the DBT. Conclusion DBT has the potential to reduce the recall-rate of BI-RADS 3 lesions and to find and diagnose malignant lesions earlier than 2D mammography alone.
机译:背景技术在高乳房密度的情况下,乳房X线摄影的灵敏度通常产生不明确或假阳性的发现,所谓的Bi-rads 3病变,必须跟进良性。数字乳房Tomosynthesis(DBT)是开发的,以减少这种求和效应。目的是为了评估额外的DBT对乳房X XMPocous Bi-Rads 3调查结果的影响,以及DBT是否可以减少到明确诊断的时间。我们分析了87例乳房X线监测的非钙化Bi-rads 3病变的材料和方法,患有受影响的乳房的另外的DBT。后续二维(2D)检查或病变的组织学结果必须可用。分析图像,特别是对于Bi-RADS类别和增量诊断准确性。此外,评估读取器互补性和辐射剂量。结果Bi-rads类别通过添加DBT改变:57.1%被评估为Bi-rad 1或2,4.6%作为Bi-rad 4,只有38.3%作为Bi-rads 3.腹部相关系数对于三位读者来说,读者互相可靠性良好。随访中没有发现假阴性检查。 9个病变是活作检的(七个良性,两个恶性)。恶性病变在DBT(Bi-rads 4)中是怀疑的。 DBT需要显着的腺体剂量。结论DBT有可能降低Bi-Rads 3病变的召回率,并仅在2D乳房X线X XMIMPOCTION之前寻找和诊断恶性病变。

著录项

  • 来源
    《Acta Radiologica》 |2018年第10期|共8页
  • 作者单位

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

    Department of Gynecology and Obstetrics University Hospital Tuebingen Tuebingen Germany;

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

    Department of Diagnostic and Interventional Radiology University Hospital Tuebingen Tuebingen;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

    Mammography; BI-RADS 3; digital breast tomosynthesis;

    机译:乳房X线术;Bi-rads 3;数字乳房汤;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号